Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 7.51170083 |
2 | viral transcription (GO:0019083) | 7.39413750 |
3 | translational termination (GO:0006415) | 7.13133761 |
4 | ribosomal small subunit biogenesis (GO:0042274) | 6.86362597 |
5 | maturation of SSU-rRNA (GO:0030490) | 6.30796242 |
6 | translational elongation (GO:0006414) | 6.21985792 |
7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.21151015 |
8 | cotranslational protein targeting to membrane (GO:0006613) | 6.11178536 |
9 | protein targeting to ER (GO:0045047) | 6.07784261 |
10 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.77985869 |
11 | protein localization to endoplasmic reticulum (GO:0070972) | 5.71856004 |
12 | respiratory electron transport chain (GO:0022904) | 5.69283108 |
13 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.64800714 |
14 | viral life cycle (GO:0019058) | 5.61892872 |
15 | cellular protein complex disassembly (GO:0043624) | 5.61774088 |
16 | * translational initiation (GO:0006413) | 5.56394237 |
17 | electron transport chain (GO:0022900) | 5.54525512 |
18 | ribosomal large subunit biogenesis (GO:0042273) | 5.43681506 |
19 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.42320626 |
20 | chaperone-mediated protein transport (GO:0072321) | 5.26729626 |
21 | protein complex disassembly (GO:0043241) | 4.93844875 |
22 | DNA deamination (GO:0045006) | 4.68823732 |
23 | macromolecular complex disassembly (GO:0032984) | 4.65851303 |
24 | oxidative phosphorylation (GO:0006119) | 4.61728407 |
25 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.49229699 |
26 | * translation (GO:0006412) | 4.45470471 |
27 | * formation of translation preinitiation complex (GO:0001731) | 4.39333715 |
28 | regulation of mitochondrial translation (GO:0070129) | 4.24687875 |
29 | protein complex biogenesis (GO:0070271) | 4.22079299 |
30 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.20776878 |
31 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.14195440 |
32 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.13114045 |
33 | NADH dehydrogenase complex assembly (GO:0010257) | 4.13114045 |
34 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.13114045 |
35 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.12135503 |
36 | protein targeting to mitochondrion (GO:0006626) | 4.05920177 |
37 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.05061273 |
38 | ATP biosynthetic process (GO:0006754) | 4.04870666 |
39 | protein targeting to membrane (GO:0006612) | 4.00309035 |
40 | mRNA catabolic process (GO:0006402) | 3.99635508 |
41 | inner mitochondrial membrane organization (GO:0007007) | 3.95926545 |
42 | DNA strand elongation (GO:0022616) | 3.94868945 |
43 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.87582909 |
44 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.85736657 |
45 | rRNA processing (GO:0006364) | 3.84822401 |
46 | establishment of protein localization to mitochondrion (GO:0072655) | 3.80248657 |
47 | RNA catabolic process (GO:0006401) | 3.78896645 |
48 | proteasome assembly (GO:0043248) | 3.76916461 |
49 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.72802487 |
50 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.71258951 |
51 | termination of RNA polymerase III transcription (GO:0006386) | 3.71258951 |
52 | DNA replication initiation (GO:0006270) | 3.70564425 |
53 | rRNA metabolic process (GO:0016072) | 3.69977126 |
54 | establishment of integrated proviral latency (GO:0075713) | 3.68589528 |
55 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.64906457 |
56 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.64834902 |
57 | spliceosomal snRNP assembly (GO:0000387) | 3.63862718 |
58 | protein localization to mitochondrion (GO:0070585) | 3.63288442 |
59 | cellular component biogenesis (GO:0044085) | 3.62240486 |
60 | telomere maintenance via recombination (GO:0000722) | 3.55271038 |
61 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.53082775 |
62 | hydrogen ion transmembrane transport (GO:1902600) | 3.47781265 |
63 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.46933515 |
64 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.46239701 |
65 | negative regulation of ligase activity (GO:0051352) | 3.46101115 |
66 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.46101115 |
67 | protein targeting (GO:0006605) | 3.44736110 |
68 | aerobic respiration (GO:0009060) | 3.44732769 |
69 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.43510965 |
70 | mitochondrial transport (GO:0006839) | 3.42369267 |
71 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.42084488 |
72 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.42084488 |
73 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.41045887 |
74 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.40956555 |
75 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.40881041 |
76 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.40881041 |
77 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.38618432 |
78 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.38618432 |
79 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.38618432 |
80 | nucleobase biosynthetic process (GO:0046112) | 3.37507955 |
81 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.37106661 |
82 | ATP synthesis coupled proton transport (GO:0015986) | 3.37106661 |
83 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.33580205 |
84 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.33580205 |
85 | GTP biosynthetic process (GO:0006183) | 3.32838343 |
86 | pseudouridine synthesis (GO:0001522) | 3.32050509 |
87 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.28902785 |
88 | ribosome biogenesis (GO:0042254) | 3.26616206 |
89 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.26252214 |
90 | spliceosomal complex assembly (GO:0000245) | 3.25082893 |
91 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.24307935 |
92 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.23429379 |
93 | DNA replication checkpoint (GO:0000076) | 3.23136318 |
94 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.22889489 |
95 | establishment of protein localization to organelle (GO:0072594) | 3.21569340 |
96 | mitotic recombination (GO:0006312) | 3.20681895 |
97 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.19441901 |
98 | 7-methylguanosine mRNA capping (GO:0006370) | 3.19108376 |
99 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.15450351 |
100 | telomere maintenance via telomere lengthening (GO:0010833) | 3.14990294 |
101 | RNA capping (GO:0036260) | 3.14778228 |
102 | 7-methylguanosine RNA capping (GO:0009452) | 3.14778228 |
103 | purine nucleobase biosynthetic process (GO:0009113) | 3.13878319 |
104 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.09511417 |
105 | protein neddylation (GO:0045116) | 3.07830791 |
106 | DNA unwinding involved in DNA replication (GO:0006268) | 3.05511871 |
107 | cullin deneddylation (GO:0010388) | 3.05428886 |
108 | establishment of viral latency (GO:0019043) | 3.03906638 |
109 | nucleoside monophosphate biosynthetic process (GO:0009124) | 3.03371751 |
110 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 3.03350192 |
111 | rRNA modification (GO:0000154) | 3.02968662 |
112 | respiratory chain complex IV assembly (GO:0008535) | 3.02870468 |
113 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.01573585 |
114 | cytochrome complex assembly (GO:0017004) | 3.01451772 |
115 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.99666690 |
116 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.99497445 |
117 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.99110044 |
118 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.98707109 |
119 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.98403690 |
120 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.95353768 |
121 | ribosome assembly (GO:0042255) | 2.93882215 |
122 | protein deneddylation (GO:0000338) | 2.91397749 |
123 | viral mRNA export from host cell nucleus (GO:0046784) | 2.91384291 |
124 | transcription from RNA polymerase I promoter (GO:0006360) | 2.87403183 |
125 | termination of RNA polymerase I transcription (GO:0006363) | 2.87331432 |
126 | CENP-A containing nucleosome assembly (GO:0034080) | 2.87187765 |
127 | positive regulation of ligase activity (GO:0051351) | 2.86198898 |
128 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.86159207 |
129 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.85426698 |
130 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.84675648 |
131 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.84675648 |
132 | cell cycle G1/S phase transition (GO:0044843) | 2.84138632 |
133 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.84138632 |
134 | ncRNA processing (GO:0034470) | 2.82027217 |
135 | positive regulation of cell cycle arrest (GO:0071158) | 2.81672329 |
136 | UTP biosynthetic process (GO:0006228) | 2.80385717 |
137 | chromatin remodeling at centromere (GO:0031055) | 2.79847722 |
138 | establishment of protein localization to membrane (GO:0090150) | 2.79500107 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.16846322 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.57104831 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.03334929 |
4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.64661861 |
5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.57415094 |
6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.56603274 |
7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.42286222 |
8 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.30644161 |
9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.27050697 |
10 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.23223917 |
11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.07598763 |
12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.96130988 |
13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.95973797 |
14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.92108760 |
15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.85432573 |
16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.83668280 |
17 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.70162519 |
18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.65164200 |
19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.52973861 |
20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.45362412 |
21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.44414018 |
22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.29633337 |
23 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.25589351 |
24 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.23907141 |
25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.22122970 |
26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.18422760 |
27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.14244562 |
28 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.11530135 |
29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.10400291 |
30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.99370624 |
31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93949988 |
32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93617040 |
33 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.91514644 |
34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.90687692 |
35 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.90051808 |
36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.86340733 |
37 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.85125021 |
38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80449455 |
39 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.77994754 |
40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.76699847 |
41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.75858223 |
42 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.72297714 |
43 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.70666735 |
44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59892039 |
45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58508187 |
46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.53737563 |
47 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.53616269 |
48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.52893041 |
49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47034752 |
50 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47007523 |
51 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42620539 |
52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42328255 |
53 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40215679 |
54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39742124 |
55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37669708 |
56 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.34957506 |
57 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.34734710 |
58 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34151232 |
59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33943973 |
60 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.33625545 |
61 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33416668 |
62 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.33297598 |
63 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.32764097 |
64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31792707 |
65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.29594985 |
66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.27816939 |
67 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.27623555 |
68 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26710251 |
69 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.22650353 |
70 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.21985607 |
71 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.19802701 |
72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17709099 |
73 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.17691883 |
74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16016029 |
75 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.14204478 |
76 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13620878 |
77 | MYC_22102868_ChIP-Seq_BL_Human | 1.10057778 |
78 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.09899821 |
79 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09167215 |
80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.06348334 |
81 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.05184606 |
82 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05119753 |
83 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.04702896 |
84 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.04405298 |
85 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03222892 |
86 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01920845 |
87 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.01838744 |
88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01573971 |
89 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00321657 |
90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99182662 |
91 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.99060726 |
92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98709333 |
93 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98035381 |
94 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.96304264 |
95 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.95822955 |
96 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.95632063 |
97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95479518 |
98 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.95465589 |
99 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.95108931 |
100 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.94750359 |
101 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.94750359 |
102 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.94750359 |
103 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.93370666 |
104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93202911 |
105 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92597888 |
106 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92007227 |
107 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90299855 |
108 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.88523931 |
109 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88462591 |
110 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.88461624 |
111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86486451 |
112 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.85083763 |
113 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.83822628 |
114 | P68_20966046_ChIP-Seq_HELA_Human | 0.82888337 |
115 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.81919907 |
116 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.81447522 |
117 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80292435 |
118 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.80047691 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 4.82817061 |
2 | MP0004957_abnormal_blastocyst_morpholog | 4.11186294 |
3 | MP0010094_abnormal_chromosome_stability | 3.66061099 |
4 | MP0009379_abnormal_foot_pigmentation | 3.56800512 |
5 | MP0003111_abnormal_nucleus_morphology | 3.54654833 |
6 | MP0003077_abnormal_cell_cycle | 3.45784464 |
7 | MP0008057_abnormal_DNA_replication | 3.39952349 |
8 | MP0008058_abnormal_DNA_repair | 3.00089995 |
9 | MP0008932_abnormal_embryonic_tissue | 2.51469278 |
10 | MP0008007_abnormal_cellular_replicative | 2.51310518 |
11 | MP0003786_premature_aging | 2.35057750 |
12 | MP0003646_muscle_fatigue | 2.02269674 |
13 | MP0002396_abnormal_hematopoietic_system | 2.01794017 |
14 | MP0009333_abnormal_splenocyte_physiolog | 1.92026956 |
15 | MP0005451_abnormal_body_composition | 1.85172251 |
16 | MP0002837_dystrophic_cardiac_calcinosis | 1.84929380 |
17 | MP0000490_abnormal_crypts_of | 1.82207345 |
18 | MP0003123_paternal_imprinting | 1.76784690 |
19 | MP0004145_abnormal_muscle_electrophysio | 1.74455432 |
20 | MP0000350_abnormal_cell_proliferation | 1.71990968 |
21 | MP0001730_embryonic_growth_arrest | 1.66843906 |
22 | MP0003315_abnormal_perineum_morphology | 1.63687391 |
23 | MP0003136_yellow_coat_color | 1.62244143 |
24 | MP0003186_abnormal_redox_activity | 1.60312660 |
25 | MP0003763_abnormal_thymus_physiology | 1.56595668 |
26 | MP0001835_abnormal_antigen_presentation | 1.49738546 |
27 | MP0002132_abnormal_respiratory_system | 1.48641306 |
28 | MP0003941_abnormal_skin_development | 1.46848173 |
29 | MP0000313_abnormal_cell_death | 1.40048248 |
30 | MP0004147_increased_porphyrin_level | 1.39770049 |
31 | MP0003718_maternal_effect | 1.34892788 |
32 | MP0002019_abnormal_tumor_incidence | 1.34739035 |
33 | MP0005670_abnormal_white_adipose | 1.34393923 |
34 | MP0010030_abnormal_orbit_morphology | 1.32715955 |
35 | MP0010352_gastrointestinal_tract_polyps | 1.30924912 |
36 | MP0002398_abnormal_bone_marrow | 1.29517613 |
37 | MP0005075_abnormal_melanosome_morpholog | 1.28029113 |
38 | MP0001697_abnormal_embryo_size | 1.25333478 |
39 | MP0001764_abnormal_homeostasis | 1.25196023 |
40 | MP0002722_abnormal_immune_system | 1.23843466 |
41 | MP0008877_abnormal_DNA_methylation | 1.22242891 |
42 | MP0002163_abnormal_gland_morphology | 1.21105220 |
43 | MP0000858_altered_metastatic_potential | 1.20920665 |
44 | MP0004808_abnormal_hematopoietic_stem | 1.20898000 |
45 | MP0000703_abnormal_thymus_morphology | 1.19743236 |
46 | MP0002148_abnormal_hypersensitivity_rea | 1.19407357 |
47 | MP0004185_abnormal_adipocyte_glucose | 1.18345880 |
48 | MP0002080_prenatal_lethality | 1.18066587 |
49 | MP0001853_heart_inflammation | 1.17933009 |
50 | MP0005330_cardiomyopathy | 1.17300928 |
51 | MP0003567_abnormal_fetal_cardiomyocyte | 1.15696916 |
52 | MP0005408_hypopigmentation | 1.15030984 |
53 | MP0000689_abnormal_spleen_morphology | 1.14568330 |
54 | MP0005671_abnormal_response_to | 1.13990356 |
55 | MP0006054_spinal_hemorrhage | 1.13136015 |
56 | MP0003806_abnormal_nucleotide_metabolis | 1.12519335 |
57 | MP0000685_abnormal_immune_system | 1.12231805 |
58 | MP0002938_white_spotting | 1.11995292 |
59 | MP0000749_muscle_degeneration | 1.10368293 |
60 | MP0009785_altered_susceptibility_to | 1.08505901 |
61 | MP0004133_heterotaxia | 1.08300226 |
62 | MP0005397_hematopoietic_system_phenotyp | 1.07712903 |
63 | MP0001545_abnormal_hematopoietic_system | 1.07712903 |
64 | MP0002429_abnormal_blood_cell | 1.07394100 |
65 | MP0003011_delayed_dark_adaptation | 1.06283023 |
66 | MP0005380_embryogenesis_phenotype | 1.04467646 |
67 | MP0001672_abnormal_embryogenesis/_devel | 1.04467646 |
68 | MP0002085_abnormal_embryonic_tissue | 1.03468777 |
69 | MP0000678_abnormal_parathyroid_gland | 1.02927967 |
70 | MP0000343_altered_response_to | 1.02387557 |
71 | MP0001800_abnormal_humoral_immune | 1.02060589 |
72 | MP0005332_abnormal_amino_acid | 1.01762642 |
73 | MP0000372_irregular_coat_pigmentation | 1.01534190 |
74 | MP0002405_respiratory_system_inflammati | 1.01340645 |
75 | MP0005379_endocrine/exocrine_gland_phen | 1.01013596 |
76 | MP0006292_abnormal_olfactory_placode | 1.00355212 |
77 | MP0002420_abnormal_adaptive_immunity | 0.99049391 |
78 | MP0000716_abnormal_immune_system | 0.98684056 |
79 | MP0005174_abnormal_tail_pigmentation | 0.97846862 |
80 | MP0001819_abnormal_immune_cell | 0.97688519 |
81 | MP0001905_abnormal_dopamine_level | 0.96685576 |
82 | MP0005266_abnormal_metabolism | 0.96264548 |
83 | MP0008995_early_reproductive_senescence | 0.95952353 |
84 | MP0002452_abnormal_antigen_presenting | 0.95273092 |
85 | MP0004381_abnormal_hair_follicle | 0.94675330 |
86 | MP0002160_abnormal_reproductive_system | 0.92602849 |
87 | MP0005501_abnormal_skin_physiology | 0.91564056 |
88 | MP0005025_abnormal_response_to | 0.91553991 |
89 | MP0003984_embryonic_growth_retardation | 0.90631363 |
90 | MP0005000_abnormal_immune_tolerance | 0.90111526 |
91 | MP0000358_abnormal_cell_content/ | 0.89753317 |
92 | MP0001529_abnormal_vocalization | 0.89485880 |
93 | MP0006036_abnormal_mitochondrial_physio | 0.89464933 |
94 | MP0002210_abnormal_sex_determination | 0.89223214 |
95 | MP0001881_abnormal_mammary_gland | 0.88916006 |
96 | MP0002088_abnormal_embryonic_growth/wei | 0.88121551 |
97 | MP0002723_abnormal_immune_serum | 0.87838810 |
98 | MP0002822_catalepsy | 0.87783101 |
99 | MP0002277_abnormal_respiratory_mucosa | 0.87082260 |
100 | MP0009697_abnormal_copulation | 0.86916765 |
101 | MP0008789_abnormal_olfactory_epithelium | 0.86612788 |
102 | MP0002095_abnormal_skin_pigmentation | 0.86010441 |
103 | MP0010307_abnormal_tumor_latency | 0.85662042 |
104 | MP0005636_abnormal_mineral_homeostasis | 0.84670379 |
105 | MP0001661_extended_life_span | 0.83343240 |
106 | MP0003121_genomic_imprinting | 0.83288983 |
107 | MP0005058_abnormal_lysosome_morphology | 0.82863197 |
108 | MP0002084_abnormal_developmental_patter | 0.82331832 |
109 | MP0005319_abnormal_enzyme/_coenzyme | 0.78753879 |
110 | MP0002086_abnormal_extraembryonic_tissu | 0.77217212 |
111 | MP0001145_abnormal_male_reproductive | 0.76538699 |
112 | MP0004197_abnormal_fetal_growth/weight/ | 0.75283744 |
113 | MP0000747_muscle_weakness | 0.74214211 |
114 | MP0002638_abnormal_pupillary_reflex | 0.73840516 |
115 | MP0003436_decreased_susceptibility_to | 0.72892656 |
116 | MP0006035_abnormal_mitochondrial_morpho | 0.72759241 |
117 | MP0005389_reproductive_system_phenotype | 0.72437772 |
118 | MP0001919_abnormal_reproductive_system | 0.72091570 |
119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70654244 |
120 | MP0000537_abnormal_urethra_morphology | 0.70411939 |
121 | MP0001727_abnormal_embryo_implantation | 0.70281545 |
122 | MP0003448_altered_tumor_morphology | 0.70175120 |
123 | MP0001873_stomach_inflammation | 0.69844698 |
124 | MP0005666_abnormal_adipose_tissue | 0.69107900 |
125 | MP0000049_abnormal_middle_ear | 0.68058727 |
126 | MP0005023_abnormal_wound_healing | 0.68030791 |
127 | MP0001346_abnormal_lacrimal_gland | 0.67938802 |
128 | MP0001293_anophthalmia | 0.67575574 |
129 | MP0002751_abnormal_autonomic_nervous | 0.67069041 |
130 | MP0000750_abnormal_muscle_regeneration | 0.65086712 |
131 | MP0001986_abnormal_taste_sensitivity | 0.64489218 |
132 | MP0005083_abnormal_biliary_tract | 0.64036129 |
133 | MP0000759_abnormal_skeletal_muscle | 0.62558718 |
134 | MP0004142_abnormal_muscle_tone | 0.61957370 |
135 | MP0005084_abnormal_gallbladder_morpholo | 0.59218488 |
136 | MP0001929_abnormal_gametogenesis | 0.58461281 |
137 | MP0004233_abnormal_muscle_weight | 0.57601656 |
138 | MP0004019_abnormal_vitamin_homeostasis | 0.57481633 |
139 | MP0009643_abnormal_urine_homeostasis | 0.55690145 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 7.49285047 |
2 | Abnormal number of erythroid precursors (HP:0012131) | 6.83902528 |
3 | Reticulocytopenia (HP:0001896) | 6.73020851 |
4 | Macrocytic anemia (HP:0001972) | 4.90220099 |
5 | Pallor (HP:0000980) | 4.59140970 |
6 | Increased muscle lipid content (HP:0009058) | 4.28742298 |
7 | Cerebral edema (HP:0002181) | 4.14983558 |
8 | Birth length less than 3rd percentile (HP:0003561) | 3.68771732 |
9 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.51694967 |
10 | Acute necrotizing encephalopathy (HP:0006965) | 3.48213845 |
11 | Aplastic anemia (HP:0001915) | 3.39488852 |
12 | Mitochondrial inheritance (HP:0001427) | 3.31341268 |
13 | Breast hypoplasia (HP:0003187) | 3.20214694 |
14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.13860809 |
15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.11649231 |
16 | Oral leukoplakia (HP:0002745) | 3.09662023 |
17 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.03154509 |
18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.03154509 |
19 | Rough bone trabeculation (HP:0100670) | 2.98605019 |
20 | Microvesicular hepatic steatosis (HP:0001414) | 2.97945652 |
21 | Ragged-red muscle fibers (HP:0003200) | 2.97943849 |
22 | Colon cancer (HP:0003003) | 2.95357544 |
23 | Carpal bone hypoplasia (HP:0001498) | 2.95058243 |
24 | 11 pairs of ribs (HP:0000878) | 2.92585647 |
25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.91535306 |
26 | Cerebral hypomyelination (HP:0006808) | 2.91205096 |
27 | Absent thumb (HP:0009777) | 2.90176198 |
28 | Leukodystrophy (HP:0002415) | 2.87379583 |
29 | Increased CSF lactate (HP:0002490) | 2.87194496 |
30 | Hepatocellular necrosis (HP:0001404) | 2.86222022 |
31 | Trismus (HP:0000211) | 2.82241898 |
32 | Selective tooth agenesis (HP:0001592) | 2.75592815 |
33 | Multiple enchondromatosis (HP:0005701) | 2.72146867 |
34 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.70832576 |
35 | Exertional dyspnea (HP:0002875) | 2.68601478 |
36 | Optic disc pallor (HP:0000543) | 2.64131261 |
37 | Progressive macrocephaly (HP:0004481) | 2.60675764 |
38 | Abnormality of renal resorption (HP:0011038) | 2.59510502 |
39 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58636275 |
40 | Patellar aplasia (HP:0006443) | 2.55990306 |
41 | Thrombocytosis (HP:0001894) | 2.54105855 |
42 | Lethargy (HP:0001254) | 2.51884162 |
43 | Progressive muscle weakness (HP:0003323) | 2.50882418 |
44 | Acute encephalopathy (HP:0006846) | 2.46543463 |
45 | Type I transferrin isoform profile (HP:0003642) | 2.45902458 |
46 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.42694233 |
47 | Renal Fanconi syndrome (HP:0001994) | 2.37970227 |
48 | Increased serum lactate (HP:0002151) | 2.37666911 |
49 | 3-Methylglutaconic aciduria (HP:0003535) | 2.36622497 |
50 | Cleft eyelid (HP:0000625) | 2.34502293 |
51 | Hepatic necrosis (HP:0002605) | 2.32953918 |
52 | Respiratory difficulties (HP:0002880) | 2.32814624 |
53 | IgM deficiency (HP:0002850) | 2.31201852 |
54 | Glycosuria (HP:0003076) | 2.28746181 |
55 | Abnormality of urine glucose concentration (HP:0011016) | 2.28746181 |
56 | Emotional lability (HP:0000712) | 2.27095788 |
57 | Stenosis of the external auditory canal (HP:0000402) | 2.26173687 |
58 | Generalized aminoaciduria (HP:0002909) | 2.24668175 |
59 | Abnormality of reticulocytes (HP:0004312) | 2.24218740 |
60 | Reduced antithrombin III activity (HP:0001976) | 2.23754633 |
61 | Degeneration of anterior horn cells (HP:0002398) | 2.23150304 |
62 | Abnormality of the anterior horn cell (HP:0006802) | 2.23150304 |
63 | CNS demyelination (HP:0007305) | 2.22975390 |
64 | Depressed nasal ridge (HP:0000457) | 2.21727316 |
65 | Exercise intolerance (HP:0003546) | 2.21142843 |
66 | Premature graying of hair (HP:0002216) | 2.20829306 |
67 | Abnormal trabecular bone morphology (HP:0100671) | 2.18810056 |
68 | Premature ovarian failure (HP:0008209) | 2.17930125 |
69 | Triphalangeal thumb (HP:0001199) | 2.17427195 |
70 | Agnosia (HP:0010524) | 2.16903016 |
71 | Microretrognathia (HP:0000308) | 2.16318082 |
72 | Abnormality of the preputium (HP:0100587) | 2.16211627 |
73 | Rhabdomyolysis (HP:0003201) | 2.15149837 |
74 | Absent radius (HP:0003974) | 2.14649077 |
75 | Abnormal number of incisors (HP:0011064) | 2.14083402 |
76 | Testicular atrophy (HP:0000029) | 2.13248786 |
77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09692469 |
78 | Dicarboxylic aciduria (HP:0003215) | 2.09692469 |
79 | Sparse eyelashes (HP:0000653) | 2.09597818 |
80 | Asplenia (HP:0001746) | 2.09441036 |
81 | Meckel diverticulum (HP:0002245) | 2.08935734 |
82 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.07842357 |
83 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.07077260 |
84 | Secondary amenorrhea (HP:0000869) | 2.06609475 |
85 | Increased intramyocellular lipid droplets (HP:0012240) | 2.06438674 |
86 | Hypoplasia of the radius (HP:0002984) | 2.05955399 |
87 | Myopathic facies (HP:0002058) | 2.04157633 |
88 | Glossoptosis (HP:0000162) | 2.02516991 |
89 | Hyperphosphaturia (HP:0003109) | 2.02277398 |
90 | Abnormality of the ileum (HP:0001549) | 2.02176796 |
91 | Horseshoe kidney (HP:0000085) | 2.01879667 |
92 | Nausea (HP:0002018) | 2.00938360 |
93 | Congenital, generalized hypertrichosis (HP:0004540) | 1.99016099 |
94 | Supernumerary spleens (HP:0009799) | 1.97963850 |
95 | Chromsome breakage (HP:0040012) | 1.97511863 |
96 | Abnormal protein glycosylation (HP:0012346) | 1.97211098 |
97 | Abnormal glycosylation (HP:0012345) | 1.97211098 |
98 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.97211098 |
99 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.97211098 |
100 | Aplasia involving forearm bones (HP:0009822) | 1.97090137 |
101 | Absent forearm bone (HP:0003953) | 1.97090137 |
102 | Myelodysplasia (HP:0002863) | 1.95987037 |
103 | Cellular immunodeficiency (HP:0005374) | 1.93262980 |
104 | X-linked dominant inheritance (HP:0001423) | 1.93123977 |
105 | Respiratory failure (HP:0002878) | 1.92568753 |
106 | Abnormal hemoglobin (HP:0011902) | 1.91884656 |
107 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.91331429 |
108 | Pancytopenia (HP:0001876) | 1.91029238 |
109 | Neoplasm of the pancreas (HP:0002894) | 1.90337477 |
110 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.89110519 |
111 | Muscle fiber atrophy (HP:0100295) | 1.87388399 |
112 | Duplicated collecting system (HP:0000081) | 1.86262238 |
113 | Bone marrow hypocellularity (HP:0005528) | 1.86159104 |
114 | Abnormal lung lobation (HP:0002101) | 1.85060305 |
115 | Missing ribs (HP:0000921) | 1.84619524 |
116 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.84556255 |
117 | Esophageal neoplasm (HP:0100751) | 1.83907362 |
118 | Neoplasm of head and neck (HP:0012288) | 1.83907362 |
119 | Abnormality of alanine metabolism (HP:0010916) | 1.83529061 |
120 | Hyperalaninemia (HP:0003348) | 1.83529061 |
121 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83529061 |
122 | Paralysis (HP:0003470) | 1.82633571 |
123 | Petechiae (HP:0000967) | 1.81175548 |
124 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.80877865 |
125 | Lymphoma (HP:0002665) | 1.80840976 |
126 | Atresia of the external auditory canal (HP:0000413) | 1.79370810 |
127 | Gliosis (HP:0002171) | 1.78438633 |
128 | Vomiting (HP:0002013) | 1.78260710 |
129 | Tracheoesophageal fistula (HP:0002575) | 1.77745162 |
130 | Abnormality of glycolysis (HP:0004366) | 1.76427267 |
131 | Increased serum pyruvate (HP:0003542) | 1.76427267 |
132 | Lactic acidosis (HP:0003128) | 1.75114742 |
133 | Methylmalonic aciduria (HP:0012120) | 1.73987453 |
134 | Facial cleft (HP:0002006) | 1.69025061 |
135 | Hypertensive crisis (HP:0100735) | 1.68714167 |
136 | Poor head control (HP:0002421) | 1.68519103 |
137 | Muscle fiber inclusion bodies (HP:0100299) | 1.67057179 |
138 | Nemaline bodies (HP:0003798) | 1.67038115 |
139 | Abnormality of the renal collecting system (HP:0004742) | 1.66980311 |
140 | Myoglobinuria (HP:0002913) | 1.64548515 |
141 | Abnormality of placental membranes (HP:0011409) | 1.64190852 |
142 | Amniotic constriction ring (HP:0009775) | 1.64190852 |
143 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.60374638 |
144 | Tinnitus (HP:0000360) | 1.58417501 |
145 | Abnormal urine phosphate concentration (HP:0012599) | 1.57439013 |
146 | Gout (HP:0001997) | 1.56126554 |
147 | Abnormal gallbladder physiology (HP:0012438) | 1.55557442 |
148 | Cholecystitis (HP:0001082) | 1.55557442 |
149 | Hyperthyroidism (HP:0000836) | 1.55278242 |
150 | Blindness (HP:0000618) | 1.55273366 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VRK2 | 5.33543752 |
2 | BUB1 | 4.54266073 |
3 | NME2 | 4.38303278 |
4 | WEE1 | 3.79631846 |
5 | STK16 | 2.72702883 |
6 | SRPK1 | 2.62346192 |
7 | CDC7 | 2.56293758 |
8 | TLK1 | 2.54864980 |
9 | PDK2 | 2.47181305 |
10 | PIM2 | 2.47157891 |
11 | VRK1 | 2.40164839 |
12 | EIF2AK1 | 2.27023913 |
13 | RPS6KB2 | 2.21136291 |
14 | TSSK6 | 2.03558001 |
15 | EIF2AK3 | 1.93825109 |
16 | TESK2 | 1.80959333 |
17 | PLK4 | 1.73584531 |
18 | MST4 | 1.72078218 |
19 | TRIB3 | 1.70149105 |
20 | SMG1 | 1.69599897 |
21 | DYRK3 | 1.68888148 |
22 | NME1 | 1.62392332 |
23 | PASK | 1.61321290 |
24 | LRRK2 | 1.47830545 |
25 | PLK1 | 1.43271972 |
26 | EPHA2 | 1.42900144 |
27 | TGFBR1 | 1.39307982 |
28 | CDK7 | 1.39083916 |
29 | AURKB | 1.38778788 |
30 | TTK | 1.38425291 |
31 | MAP4K1 | 1.31741735 |
32 | BRSK2 | 1.30682880 |
33 | NEK2 | 1.28222928 |
34 | MKNK1 | 1.26867031 |
35 | ACVR1B | 1.25773560 |
36 | KDR | 1.24116531 |
37 | AURKA | 1.23426689 |
38 | MAPKAPK3 | 1.22686132 |
39 | ZAK | 1.21403670 |
40 | OBSCN | 1.16115526 |
41 | TESK1 | 1.15286294 |
42 | PBK | 1.14987810 |
43 | PIM1 | 1.14107773 |
44 | ATR | 1.12687159 |
45 | STK10 | 1.11457221 |
46 | BLK | 1.06841471 |
47 | PAK4 | 1.05581245 |
48 | MAP3K12 | 1.03578925 |
49 | ILK | 1.00570399 |
50 | TAF1 | 0.99425086 |
51 | MAP3K8 | 0.99366051 |
52 | PLK3 | 0.97342651 |
53 | RPS6KA4 | 0.95146297 |
54 | NEK1 | 0.89636093 |
55 | MAP3K11 | 0.88700332 |
56 | RPS6KA5 | 0.85018589 |
57 | PHKG1 | 0.83877662 |
58 | PHKG2 | 0.83877662 |
59 | CSNK2A2 | 0.82049590 |
60 | STK4 | 0.80640579 |
61 | CSNK2A1 | 0.80190104 |
62 | BTK | 0.79295414 |
63 | CHEK2 | 0.78650403 |
64 | ZAP70 | 0.77745428 |
65 | CDK19 | 0.77196499 |
66 | MAP2K3 | 0.76255330 |
67 | PAK1 | 0.76078856 |
68 | IKBKB | 0.75225926 |
69 | MKNK2 | 0.74613664 |
70 | DYRK2 | 0.73329891 |
71 | EEF2K | 0.73115282 |
72 | LIMK1 | 0.70844456 |
73 | MYLK | 0.70272493 |
74 | CDK8 | 0.68698943 |
75 | MAP3K3 | 0.68697154 |
76 | BRAF | 0.68357530 |
77 | RIPK4 | 0.68107056 |
78 | IRAK4 | 0.68050136 |
79 | IRAK3 | 0.67623858 |
80 | TEC | 0.67437767 |
81 | BCKDK | 0.66613655 |
82 | CHEK1 | 0.66402585 |
83 | PRKCI | 0.65056132 |
84 | EIF2AK2 | 0.65032152 |
85 | CCNB1 | 0.64964470 |
86 | GRK6 | 0.64948067 |
87 | BRSK1 | 0.63663393 |
88 | ARAF | 0.60128454 |
89 | TXK | 0.59878116 |
90 | CLK1 | 0.58353927 |
91 | TAOK2 | 0.58313337 |
92 | CDK4 | 0.57672186 |
93 | FLT3 | 0.57381197 |
94 | IRAK2 | 0.57364076 |
95 | AKT2 | 0.56610616 |
96 | MAPKAPK5 | 0.53722021 |
97 | DAPK3 | 0.53492190 |
98 | SYK | 0.52665137 |
99 | SCYL2 | 0.50484480 |
100 | DAPK1 | 0.50168699 |
101 | ERN1 | 0.46302068 |
102 | CDK2 | 0.46054534 |
103 | ABL2 | 0.45802047 |
104 | MAP2K6 | 0.44794881 |
105 | LYN | 0.43090137 |
106 | KIT | 0.42912753 |
107 | MUSK | 0.42689686 |
108 | MAP2K2 | 0.42660770 |
109 | ATM | 0.42519651 |
110 | TYK2 | 0.40183628 |
111 | ALK | 0.39111296 |
112 | STK24 | 0.37623366 |
113 | MAP3K10 | 0.36569574 |
114 | YES1 | 0.35559027 |
115 | MAPKAPK2 | 0.32977485 |
116 | RPS6KA6 | 0.31449052 |
117 | LCK | 0.31415708 |
118 | NUAK1 | 0.30660955 |
119 | EPHB2 | 0.29735284 |
120 | CSNK1G3 | 0.29358505 |
121 | MARK3 | 0.29223503 |
122 | TBK1 | 0.24808803 |
123 | CSNK1E | 0.24711776 |
124 | MAPK12 | 0.24392203 |
125 | CAMK2G | 0.23771691 |
126 | PRKG2 | 0.23384490 |
127 | CDK11A | 0.22879580 |
128 | PRKCD | 0.22025703 |
129 | CDK1 | 0.21398539 |
130 | RPS6KA1 | 0.19234584 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 6.12379431 |
2 | Proteasome_Homo sapiens_hsa03050 | 4.23346540 |
3 | DNA replication_Homo sapiens_hsa03030 | 4.07541039 |
4 | RNA polymerase_Homo sapiens_hsa03020 | 3.74124668 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 3.52857781 |
6 | Spliceosome_Homo sapiens_hsa03040 | 3.05823753 |
7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.90608724 |
8 | Base excision repair_Homo sapiens_hsa03410 | 2.56098982 |
9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.54096060 |
10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.50160718 |
11 | Homologous recombination_Homo sapiens_hsa03440 | 2.49768618 |
12 | RNA transport_Homo sapiens_hsa03013 | 2.39630306 |
13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.30152196 |
14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.14748950 |
15 | Protein export_Homo sapiens_hsa03060 | 1.84894566 |
16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.75837702 |
17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.74593677 |
18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.74592672 |
19 | Cell cycle_Homo sapiens_hsa04110 | 1.74245998 |
20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71521717 |
21 | Basal transcription factors_Homo sapiens_hsa03022 | 1.68509740 |
22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.62805778 |
23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.62727185 |
24 | RNA degradation_Homo sapiens_hsa03018 | 1.60762274 |
25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46911735 |
26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41641002 |
27 | Purine metabolism_Homo sapiens_hsa00230 | 1.35237003 |
28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.33701306 |
29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29135570 |
30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.25658774 |
31 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.21321172 |
32 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.17744396 |
33 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.05803788 |
34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.01969632 |
35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01140452 |
36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97968792 |
37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.90657164 |
38 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90182308 |
39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88342125 |
40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80218922 |
41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78971078 |
42 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78892840 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77645735 |
44 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77003566 |
45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.76668116 |
46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71345324 |
47 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71257772 |
48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68008422 |
49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64390471 |
50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64312493 |
51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60391716 |
52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60104377 |
53 | Legionellosis_Homo sapiens_hsa05134 | 0.56479237 |
54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52380022 |
55 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.51574455 |
56 | Allograft rejection_Homo sapiens_hsa05330 | 0.51563664 |
57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49963612 |
58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49221240 |
59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49036770 |
60 | Asthma_Homo sapiens_hsa05310 | 0.48713229 |
61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.45863552 |
62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45062390 |
63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45054613 |
64 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44828238 |
65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.44802168 |
66 | Peroxisome_Homo sapiens_hsa04146 | 0.44021920 |
67 | Measles_Homo sapiens_hsa05162 | 0.42989329 |
68 | Apoptosis_Homo sapiens_hsa04210 | 0.41578225 |
69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41171522 |
70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39865966 |
71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37812769 |
72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37619913 |
73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37535037 |
74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37388430 |
75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36942107 |
76 | Alcoholism_Homo sapiens_hsa05034 | 0.36458085 |
77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35998136 |
78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35751327 |
79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34961322 |
80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34881327 |
81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34832811 |
82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34312917 |
83 | Shigellosis_Homo sapiens_hsa05131 | 0.33492755 |
84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.32218041 |
85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31205945 |
86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.29948082 |
87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29702041 |
88 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29527869 |
89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.29142280 |
90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.29067975 |
91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28312720 |
92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27464263 |
93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.27401204 |
94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.27202713 |
95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26013092 |
96 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.24566532 |
97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24469895 |
98 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23734412 |
99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.23298182 |
100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22914309 |
101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21405475 |
102 | Leishmaniasis_Homo sapiens_hsa05140 | 0.21345837 |
103 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21267805 |
104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21188432 |
105 | Influenza A_Homo sapiens_hsa05164 | 0.19452099 |
106 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.18308347 |
107 | Hepatitis B_Homo sapiens_hsa05161 | 0.18244873 |
108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.17584303 |
109 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.15751951 |
110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.15548556 |
111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.15170485 |
112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.15134222 |
113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.15109296 |
114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.14995012 |
115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14714894 |
116 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.14323879 |
117 | Malaria_Homo sapiens_hsa05144 | 0.12435863 |
118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.12397704 |
119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11042277 |
120 | Carbon metabolism_Homo sapiens_hsa01200 | 0.10815823 |
121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.10636363 |
122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.10389552 |
123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.10096474 |
124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09938860 |
125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.08979201 |
126 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.07552378 |
127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.07049545 |
128 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.02827660 |
129 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.02231823 |
130 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.02184824 |